Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment

Transplant Proc. 2002 May;34(3):955-6. doi: 10.1016/s0041-1345(02)02714-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Child
  • Humans
  • Infant
  • Intestine, Small / transplantation*
  • Lymphoproliferative Disorders / drug therapy*
  • Male
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / immunology
  • Retrospective Studies
  • Rituximab
  • Transplantation, Homologous / pathology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab